KIADIS PHARMA (UK) Today

KIADIS PHARMA NV cannot be verified against its exchange. It appears KIADIS PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on London Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

KIADIS PHARMA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. KIADIS PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding KIADIS PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
KIADIS PHARMA NV is not currently marked as verified by its exchange. Report It!
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of KIADIS PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
KIADIS PHARMA NV (0RBP) is traded on London Stock Exchange in UK and employs 97 people. The company currently falls under 'Small-Cap' category with current market capitalization of 152.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KIADIS PHARMA's market, we take the total number of its shares issued and multiply it by KIADIS PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. KIADIS PHARMA NV has 20.12 M outstanding shares. KIADIS PHARMA NV has accumulated about 60.31 M in cash with (24.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.48.
Check KIADIS PHARMA Probability Of Bankruptcy

KIADIS Stock Against Markets

Picking the right benchmark for KIADIS PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in KIADIS PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for KIADIS PHARMA is critical whether you are bullish or bearish towards KIADIS PHARMA NV at a given time.
KIADIS PHARMA NV cannot be verified against its exchange. It appears KIADIS PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on London Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

KIADIS PHARMA Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with KIADIS PHARMA stock to make a market-neutral strategy. Peer analysis of KIADIS PHARMA could also be used in its relative valuation, which is a method of valuing KIADIS PHARMA by comparing valuation metrics with similar companies.
MAST ENERGY DEVELOPMAmerican AirlinesAlcoa CorpApple IncBest BuyCitigroupSentinelone IncCVS CorpChevron CorpHome DepotInternational BusinessIntel CorpMetlifeATT IncTarget Corp
 Risk & Return  Correlation

Invested in KIADIS PHARMA NV?

The danger of trading KIADIS PHARMA NV is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of KIADIS PHARMA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than KIADIS PHARMA. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile KIADIS PHARMA NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Tools for KIADIS Stock

When running KIADIS PHARMA NV price analysis, check to measure KIADIS PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KIADIS PHARMA is operating at the current time. Most of KIADIS PHARMA's value examination focuses on studying past and present price action to predict the probability of KIADIS PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move KIADIS PHARMA's price. Additionally, you may evaluate how the addition of KIADIS PHARMA to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go